John Kastelein: Exploring the Biology of Cardiovascular Disease at BioCentury Grand Rounds Europe
John Kastelein, Co-Founder and Chief Scientific Officer at NewAmsterdam Pharma, Operating Partner of Forbion Capital Management, Chief Executive Officer of Vascular Research Network B.V., Co-Founder of Dezima Pharma and UniQure, shared a post on LinkedIn:
“I recently participated in BioCentury Inc. Grand Rounds Europe in Amsterdam, where I joined colleagues to discuss how advances in vascular biology, genetics, inflammation, thrombosis, and metabolism are changing the way we understand cardiovascular disease.
These mechanisms are deeply interconnected. Understanding why they work the way they do, and how we should scientifically approach them from different points of view, may help inform the next generation of cardiovascular therapies.
That is what makes discussions like this so valuable. Progress requires us to look beyond traditional boundaries, revisit longstanding assumptions, and remain open to where the research and the data lead.
I appreciated the opportunity to learn from my fellow panelists, Peter Carmeliet, Luca Andrea Lotta, and Pieter H. Reitsma, each of whom brought a valuable perspective to the conversation.
Thank you to BioCentury and to our moderator, Vanessa Carle, for bringing us together for such a thoughtful discussion.”

Stay updated with Hemostasis Today.
-
Sep 30, 2026, 22:28Recent Mechanical Risk Factors and Young-Onset Cryptogenic Ischemic Stroke – American Heart Association International
-
Sep 30, 2026, 22:22Expert Consensus on Inferior Vena Cava Thrombosis – Thrombosis and Haemostasis Journal
-
Sep 30, 2026, 22:21Markus Abeln: How Platelets, Coagulation, Glycosylation, and Complement Regulate Placental Blood Flow
-
Sep 30, 2026, 22:19Fatma Al Arbawi: Studying Blood Clot Mechanics to Understand Aspirin Resistance and Thrombosis
-
Sep 30, 2026, 22:17Sudhir Kumar: Stroke is a Medical Emergency – and Every Minute Matters
-
Sep 30, 2026, 22:15Luisa Medeiros Visentini: Our Research on Cognitive Impairment After CVT Cited in the International Journal of Stroke
-
Sep 30, 2026, 21:50Jagat Narula: Connecting Cardiovascular Health and Sickle Cell Disease on World Heart Day 2026
-
Sep 30, 2026, 21:36Mark Murphy: Irish Heart Foundation Meets With Senator Teresa Costello on World Heart Day
-
Sep 30, 2026, 21:34Sadashiva Pai: How Pancreatic Cancer Uses Blood Clotting to Evade Immune Attack